Commons Capital LP
Becton, Dickinson and Company
Ventro, Inc. (formerly Chemdex Corp.)
B.S., Biochemistry – Virginia Tech
M.B.A. – The Wharton School at the University of Pennsylvania
Jim P. O'Connell
Principal and Kauffman Fellow, Healthcare
Experienced in healthcare and business development, Jim brings operational, financial and entrepreneurial expertise to the table.
At Safeguard, Jim is responsible for screening deals, conducting due diligence for various acquisition opportunities and supporting Safeguard's healthcare partner companies.
Jim has eight years of operational, financial and entrepreneurial experience in healthcare and the life sciences. During business school, Jim served as Summer Associate for Quaker BioVentures and Commons Capital, and also completed an internship at Liquidia Technologies in business development. Prior, he was in the Corporate Ventures/Business Development group of Becton Dickinson, a F500 medical technology firm. From 1998-2001, Jim held progressive positions in Sales, Marketing and Business Development at Chemdex, a pioneering startup that raised $450M in financing. Jim started his career in R&D at Biosite and helped developed the firm’s blockbuster BNP panel diagnosing congestive heart failure ($600+M sales to date).
Jim received a B.S. in biochemistry from Virginia Tech and served as class president for four years. Jim also received an M.B.A. from The Wharton School at the University of Pennsylvania, where he led the University of Pennsylvania’s $70K Business Plan Competition and received a fellowship in healthcare entrepreneurship.